Summary
An association between renal microvascular complications and hemorheological alterations has been suggested in diabetes mellitus. Therefore, a hemorheologic approach in the treatment of diabetic microproteinuria has been proposed. Eighty-two type I and type II diabetic patients with microproteinuria were randomized and assigned to two different protocols: protocol A, patients treated with pentoxifylline (Trental 400Ŗ); protocol B, patients without hemorheologic treatment, in whom hypoglycemic therapy was just more strictly enforced. A significant improvement of the hemorheologic pattern and a significant marked reduction of albumin excretion rate and proteinuria was found in diabetic patients treated with pentoxifylline, independently of the degree of metabolic control. These results were readily achieved and were confirmed throughout the study. Moreover, these results were comparable to those obtained in diabetic patients of protocol B. Pentoxifylline might therefore be considered as the first useful therapeutic agent in the treatment of diabetic microproteinuria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armitage P.: Statistical methods in medical research. Blackwell Sci. Publ., Oxford, 1971.
Bradford M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding — Analyt. Biochem.72, 248, 1976.
Cordaro C., Carandente O.: Esperienze pratiche sulla metodica di filtrazione eritrocitaria — La Ricerca Clin. Lab.10 (Suppl. 1), 113, 1980.
Christiansen J. S.: On the pathogenesis of the increased glomerular filtration rate in short-term insulin-dependent diabetes — Danish med. Bull.31, 349, 1984.
Christiansen J. S., Frandsen M., Parving H.-H.: Effect of intravenous glucose infusion on renal function in normal man and insulin-dependent diabetics — Diabetologia21, 368, 1981.
Di Perri T., Guerrini M.: Placebo controlled double blind study with pentoxifylline of walking performance in patients with intermittent claudication — Angiology30, 40, 1983.
Esmatjes E., Fernandez M. R., Halperin I., Camps J., Gaya J., Arroyo V., Rivera F., Figuerolo D.: Renal haemodynamic abnormalities in patients with short term insulin dependent diabetes mellitus: role of prostaglandins — J. clin. Endocrinol.60, 1231, 1985.
Guerrini M., Pecchi S., Rossi C., Cappelli R., Pieragalli D., Acciavatti A.: Effect of pentoxifylline on blood hyperviscosity and peripheral haemodynamics in patients with peripheral obliterating arterial disease — Pharmatherapeutica3 (Suppl. 1), 52, 1983.
Mancini G., Carbonara A. O., Heremans J. F.: Immunochemical quantitation of antigens by single radial immunodiffusion — Immunochemistry2, 235, 1965.
Mogensen C. E.: Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes — New Engl. J. Med.310, 356, 1984.
Mogensen C. E.: Predicting diabetic nephropathy in insulin-dependent patients — New Engl. J. Med.311, 89, 1984.
Muggeo M., Calabró A., Businaro V., Patussi L., Volpe A., Signorini G. P., Crepaldi G.: Blood clotting, fibrinolytic and haemorheological parameters in ischaemic vascular disease: the effects of pentoxifylline in the treatment of acute cerebral vascular disease — Pharmatherapeutica3 (Suppl. 1), 74, 1983.
Müller R., Lehrach F.: Haemorheological role of platelet aggregation and hypercoagulability in microcirculation: therapeutical approach with pentoxifylline — Pharmatherapeutica2, 372, 1980.
Paisey R. B., Harkness J., Hartog M., Chadwick T.: The effect of improvement in diabetic control on plasma and whole-blood viscosity — Diabetologia19, 345, 1980.
Reid H. L., Barnes A. J., Lock P. I., Dormandy J. A., Dormandy T. L.: A simple method for measuring erythrocyte deformability — J. clin. Pathol.29, 855, 1976.
Simpson L. O.: A hypothesis proposing increased blood viscosity as a cause of proteinuria and increased vascular permeability — Nephron31, 89, 1982.
Simpson L. O.: Intrinsic stiffening of red blood cells as the fundamental cause of diabetic nephropathy and microangiopathy — Nephron39, 344, 1985.
Solerte S. B., Adamo S., Viola C., Carnevale Schianca G. P., Crippa A., Ferrari E.: Modificazioni emoreologiche e proteinuria nel diabete mellito complicato — G. ital. Diabetol.4, 245, 1984.
Solerte S. B., Ferrari E.: Diabetic retinal vascular complications, erythrocyte filtrability and pentoxifylline. Results of a two years follow-up study — Pharmatherapeutica4, 341, 1985.
Solerte S. B., Piovella F., Viola C., Carnevale Schianca G. P., Gamba G., Fioravanti M., Ferrari E.: Plasma fibronectin, von Willebrand factor antigen and blood rheology. Association with diabetic microvascular disease — Acta diabetol. lat.22, 239, 1985.
Solerte S. B., Viola C., Adamo S., Carnevale Schianca G. P., Dalzano M., Ferrari E.: Proteinuria, microalbuminuria ed iperviscosità nel diabete mellito insulino-dipendente (tipo I). In:Pozza G., Carandente O. (Eds): Emoreologia in laboratorio ed in clinica — La Ricerca Clin. Lab.15 (Suppl. 1), 383, 1985.
Viberti G. C., Hill R. D., Jarrett R. J., Argyropoulos A., Mahmud U., Keen H.: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus — Lanceti, 430, 1982.
Viberti G. C., Keen H.: The patterns of proteinuria in diabetes mellitus. Relevance to pathogenesis and prevention of diabetic nephropathy — Diabetes33, 686, 1984.
Viberti G. C., Mackintosh D., Bilous R. W., Pickup J. C., Keen H.: Proteinuria in diabetes mellitus: role of spontaneous and experimental variation of glycaemia — Kidney Int.21, 714, 1982.
Viberti G. C., Pickup J. C., Jarrett R. J., Keen H.: Effect of control of blood glucose on urinary excretion of albumin and β2microglobulin in insulin-dependent diabetes — New Engl. J. Med.300, 638, 1979.
Wiseman M. J., Saunders A. J., Keen H., Viberti G. C.: Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes — New Engl. J. Med.312, 617, 1985.
Wiseman M., Viberti G., Mackintosh D., Jarrett R. J., Keen H.: Glycaemia, arterial pressure and micro-albuminuria in type 1 (insulin-dependent) diabetes mellitus — Diabetologia26, 401, 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Solerte, S.B., Fioravanti, M., Bozzetti, A. et al. Pentoxifylline, albumin excretion rate and proteinuria in type I and type II diabetic patients with microproteinuria. Results of a short-term randomized study. Acta diabet. lat 23, 171–177 (1986). https://doi.org/10.1007/BF02624677
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624677